Cargando…
Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort
BACKGROUND: The objective of this study was to assess the treatment outcomes and prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) undergoing radiotherapy (RT). MATERIALS AND METHODS: A retrospective cohort from a single institution, from 2000 to 2015, includi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086709/ https://www.ncbi.nlm.nih.gov/pubmed/33948297 http://dx.doi.org/10.5603/RPOR.a2021.0002 |
_version_ | 1783686560569360384 |
---|---|
author | Viani, Gustavo Arruda Faustino, Alexandre Ciufi Danelichen, Anielle Freitas Bendo Matsuura, Fernando Kojo Neves, Leonardo Vicente Fay Fernandes, Marco Henrique Fernandes, Juliana Pavoni |
author_facet | Viani, Gustavo Arruda Faustino, Alexandre Ciufi Danelichen, Anielle Freitas Bendo Matsuura, Fernando Kojo Neves, Leonardo Vicente Fay Fernandes, Marco Henrique Fernandes, Juliana Pavoni |
author_sort | Viani, Gustavo Arruda |
collection | PubMed |
description | BACKGROUND: The objective of this study was to assess the treatment outcomes and prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) undergoing radiotherapy (RT). MATERIALS AND METHODS: A retrospective cohort from a single institution, from 2000 to 2015, including patients older than 65 years old with LAHNC (stage III–IVa) treated by RT combined or not with chemotherapy (CRT). Univariate and multivariate analysis (MVA) were performed to identify prognostic factors associated with overall survival (OS), cancer-specific survival (CS), and locoregional control (LRC). A p-value < 0.05 was considered significant. RESULTS: 220 patients with LAHNC and > 65 years of age were identified. The median follow-up was 3.8 years, the 3/5 years estimated OS, CS, and LRC rate was 40%/30%, 49%/34%, 76%/45%, respectively. In the univariate analysis, clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.035), Karnofsky performance status (KPS, 60–70, p = 0.03) and tumor site (other than vs. hypopharynx, p = 0.0001) were associated with lower OS. Patients with clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.015), N stage (N0/1 vs. N2/3, p = 0.04), (KPS 60–70, p = 0.04) and tumor site (other than vs. hypopharynx, p = 0.0001) had worst CS. For the LRC, clinical stage (III vs. IVa/b, p = 0.02), tumor stage (T1/2 vs. T3/4, p = 0.02), treatment type (CRT vs. RT, p = 0.02), RT technique (IMRT vs. 2DRT/3DRT, p = 0.0001), and tumor site (other than vs. hypopharynx, p = 0.02) were significant. In the MVA, KPS maintained significant for OS and CS. For LRC, clinical stage (Iva/b, p = 0.007), tumor stage (T3/4, p = 0.047) and radiotherapy technique other than IMRT (p = 0.0001) were significant. CONCLUSION: The OS, CS, and LRC were associated with several prognostic factors. The clinical performance was the main marker of OS and CS. Chemoradiation should be offered to selected elderly patients using IMRT to improve LRC. |
format | Online Article Text |
id | pubmed-8086709 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Via Medica |
record_format | MEDLINE/PubMed |
spelling | pubmed-80867092021-05-03 Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort Viani, Gustavo Arruda Faustino, Alexandre Ciufi Danelichen, Anielle Freitas Bendo Matsuura, Fernando Kojo Neves, Leonardo Vicente Fay Fernandes, Marco Henrique Fernandes, Juliana Pavoni Rep Pract Oncol Radiother Research Paper BACKGROUND: The objective of this study was to assess the treatment outcomes and prognostic factors of elderly patients with locally advanced head and neck cancer (LAHNC) undergoing radiotherapy (RT). MATERIALS AND METHODS: A retrospective cohort from a single institution, from 2000 to 2015, including patients older than 65 years old with LAHNC (stage III–IVa) treated by RT combined or not with chemotherapy (CRT). Univariate and multivariate analysis (MVA) were performed to identify prognostic factors associated with overall survival (OS), cancer-specific survival (CS), and locoregional control (LRC). A p-value < 0.05 was considered significant. RESULTS: 220 patients with LAHNC and > 65 years of age were identified. The median follow-up was 3.8 years, the 3/5 years estimated OS, CS, and LRC rate was 40%/30%, 49%/34%, 76%/45%, respectively. In the univariate analysis, clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.035), Karnofsky performance status (KPS, 60–70, p = 0.03) and tumor site (other than vs. hypopharynx, p = 0.0001) were associated with lower OS. Patients with clinical stage (III vs. IVa/b, p = 0.01), tumor stage (T1/2 vs. T3/4, p = 0.015), N stage (N0/1 vs. N2/3, p = 0.04), (KPS 60–70, p = 0.04) and tumor site (other than vs. hypopharynx, p = 0.0001) had worst CS. For the LRC, clinical stage (III vs. IVa/b, p = 0.02), tumor stage (T1/2 vs. T3/4, p = 0.02), treatment type (CRT vs. RT, p = 0.02), RT technique (IMRT vs. 2DRT/3DRT, p = 0.0001), and tumor site (other than vs. hypopharynx, p = 0.02) were significant. In the MVA, KPS maintained significant for OS and CS. For LRC, clinical stage (Iva/b, p = 0.007), tumor stage (T3/4, p = 0.047) and radiotherapy technique other than IMRT (p = 0.0001) were significant. CONCLUSION: The OS, CS, and LRC were associated with several prognostic factors. The clinical performance was the main marker of OS and CS. Chemoradiation should be offered to selected elderly patients using IMRT to improve LRC. Via Medica 2021-02-25 /pmc/articles/PMC8086709/ /pubmed/33948297 http://dx.doi.org/10.5603/RPOR.a2021.0002 Text en © 2021 Greater Poland Cancer Centre https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
spellingShingle | Research Paper Viani, Gustavo Arruda Faustino, Alexandre Ciufi Danelichen, Anielle Freitas Bendo Matsuura, Fernando Kojo Neves, Leonardo Vicente Fay Fernandes, Marco Henrique Fernandes, Juliana Pavoni Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
title | Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
title_full | Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
title_fullStr | Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
title_full_unstemmed | Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
title_short | Radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
title_sort | radiotherapy for locally advanced head and neck cancer in elderly patients: results and prognostic factors a single cohort |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086709/ https://www.ncbi.nlm.nih.gov/pubmed/33948297 http://dx.doi.org/10.5603/RPOR.a2021.0002 |
work_keys_str_mv | AT vianigustavoarruda radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort AT faustinoalexandreciufi radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort AT danelichenaniellefreitasbendo radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort AT matsuurafernandokojo radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort AT nevesleonardovicentefay radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort AT fernandesmarcohenrique radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort AT fernandesjulianapavoni radiotherapyforlocallyadvancedheadandneckcancerinelderlypatientsresultsandprognosticfactorsasinglecohort |